News By Tag
* More Tags...
News By Place
Kalos Therapeutics, Inc. to Present at February 2nd, 2012 BIOCOM's Event
Kalos Therapeutics, Inc. Co Founder George Colberg to Present at BIOCOM's Global Life Science Partnering Conference 2012, La Jolla, CA, USA,Thursday February 2nd, 2012 Being held at the Lodge at Torrey Pines in La Jolla CA
The Company continues to move its core products forward in virulent cancers like pancreatic and ovarian, in a unique manner eliminating chemo-related side effect while leveraging the natural effects of ANP peptides in the body, whereby producing a cytostatic approach to treating these cancers, while reducing pain and edema related to abdominal cancers.
About Kalos Therapeutics:
Kalos is a uniquely positioned biomedical company whose family of peptide therapeutics has previous successful clinical experience in humans. Kalos is pioneering an approach to treat cancer by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.
More information can be found on Kalos' web site at http://www.kalostherapeutics.com
Kalos Therapeutics George Colberg, Executive Chairman 858-385-1290 or firstname.lastname@example.org
SOURCE: Kalos Therapeutics, North America, California
INDUSTRY KEYWORDS: Biotechnology, Clinical Trials, Oncology, AMD, Pharmaceutical, Research, Health,
# # #
Kalos Therapeutics, Inc. is targeting diseases causedby an abnormally high growth rate of cells (hyperproliferation)